[{"id":"578aac1e-21ae-4468-a019-eff852819b49","acronym":"","url":"https://clinicaltrials.gov/study/NCT04840004","created_at":"2021-04-09T16:56:21.275Z","updated_at":"2024-07-02T16:35:51.405Z","phase":"Phase 2","brief_title":"Efficacy and Safety of PVT-1 Treatment in Patients With Advanced Non-Small Cell Lung Cancer","source_id_and_acronym":"NCT04840004","lead_sponsor":"PlusVitech S.L.","biomarkers":" EGFR • ROS1","pipe":"","alterations":" ","tags":["EGFR • ROS1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PVT-1"],"overall_status":"Recruiting","enrollment":" Enrollment 24","initiation":"Initiation: 03/10/2021","start_date":" 03/10/2021","primary_txt":" Primary completion: 12/31/2025","primary_completion_date":" 12/31/2025","study_txt":" Completion: 12/31/2025","study_completion_date":" 12/31/2025","last_update_posted":"2023-04-05"}]